Technical Analysis for ASCW - Asc Biosciences Inc.

Grade Last Price % Change Price Change
grade F 2.5 -75.37% -7.6500
ASCW closed down 75.37 percent on Thursday, January 3, 2019, on 56 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
See historical ASCW trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Older signals for ASCW ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


ASC Biosciences, Inc., a biotechnology company, develops products that restore, maintain, and improve tissue function in humans. It offers Chondrofelt, a medical device to repair articular cartilage defects caused by trauma/osteoarthritis; PeriGen, a product that regenerates peritoneum following abdominal surgery to prevent surgical adhesions; ChondroGen, a product to regenerate articular cartilage and subchondral bone in patients with cartilage damage resulting from sports injury, traumatic injury, and osteoarthritis; and RhytiGen, a product that utilizes MASCs to form connective tissue when injected under the skin. The company also provides MeniGen, a product that incorporates MASCs into a matrix for use as a universal allogeneic meniscus graft; OsteoGen, a product that utilizes MASCs in polylactic acid polymers/purchased porous bone substitutes as three-dimensional scaffolds for the healing of fractures, non-union fractures, and craniofacial defects; and DermiGen, a product that utilizes MASCs to form the cell types in skin, fibroblasts in the dermis, and keratinocytes in the epidermis. ASC Biosciences, Inc. was founded in 2015 and is based in Palm Desert, California.
Medicine Biotechnology Medical Specialties RTT Arthritis Osteoarthritis Skeletal System Connective Tissue Cartilage Skeletal Disorders Musculoskeletal System Osteochondritis Dissecans A Medical Device Traumatic Injury

Is ASCW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 10.15
52 Week Low 2.5
Average Volume 177
200-Day Moving Average 0.0000
50-Day Moving Average 9.9220
20-Day Moving Average 9.7675
10-Day Moving Average 9.3850
Average True Range 0.5496
ADX 15.19
+DI 0.8425
-DI 100.0000
Chandelier Exit (Long, 3 ATRs ) 8.5012
Chandelier Exit (Short, 3 ATRs ) 4.1488
Upper Bollinger Band 13.1021
Lower Bollinger Band 6.4329
Percent B (%b) -0.59
BandWidth 68.2795
MACD Line -0.5896
MACD Signal Line -0.0956
MACD Histogram -0.494
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.5000
Resistance 3 (R3) 2.5000 2.5000 2.5000
Resistance 2 (R2) 2.5000 2.5000 2.5000 2.5000
Resistance 1 (R1) 2.5000 2.5000 2.5000 2.5000 2.5000
Pivot Point 2.5000 2.5000 2.5000 2.5000 2.5000
Support 1 (S1) 2.5000 2.5000 2.5000 2.5000 2.5000
Support 2 (S2) 2.5000 2.5000 2.5000 2.5000
Support 3 (S3) 2.5000 2.5000 2.5000
Support 4 (S4) 2.5000